Medicare Enrolled

Dr. Travis Van Meter, MD

Radiation Oncology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
9101 N CENTRAL EXPY STE 550, Dallas, TX 75231
4694589800
In practice since 2006 (19 years)
NPI: 1750339461 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Van Meter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Van Meter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Van Meter

Dr. Travis Van Meter is a radiation oncology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Van Meter performed 18,174 Medicare services across 1,197 unique beneficiaries.

Between the years covered by Open Payments, Dr. Van Meter received a total of $39,994 from 36 pharmaceutical and/or device companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Van Meter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 4% volume in TX $39,994 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18,174
Medicare services
Top 4% in TX for radiation oncology
1,197
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~957 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, propofol, 10 mg 7,425 $0 $0
Contrast dye for imaging, lower concentration 3,398 $0 $19
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
3,392 $0 $19
Anti-nausea injection (ondansetron/Zofran) 938 $0 $0
Bupivacaine injection, 0.5 mg
An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg.
711 $0 $0
Lidocaine HCl injection for IV infusion, 10 mg
Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion.
560 $0 $0
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
145 $0 $1
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
139 $2 $150
Radiologist review of additional artery image
A radiologist reviews an additional image of an artery. This step involves professional interpretation of the imaging data.
138 $76 $339
Ultrasound guidance for blood vessel access
Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood.
116 $31 $175
Cefazolin sodium injection, 500 mg
An injection of 500 mg of cefazolin sodium, an antibiotic medication, administered into the body.
110 $1 $3
Heparin sodium injection, per 1000 units
An injection of heparin sodium, a blood thinner, administered in units of 1000.
102 $0 $1
Radiologist review of abdominal artery image
A radiologist reviews images of the arteries in the abdomen to assess their structure and function.
90 $133 $593
Arterial catheter insertion, initial third order branch
Insertion of a tube into an abdominal, pelvic, or leg artery, specifically targeting the initial third order branch.
80 $622 $7,195
Additional blood vessel ultrasound evaluation
An ultrasound exam of a blood vessel that includes a radiologist's review. This code applies to each additional vessel evaluated beyond the initial one.
73 $132 $807
Midazolam injection, per 1 mg
Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments.
67 $0 $0
Arterial tube insertion, additional vessels
This code covers the insertion of a tube into an additional artery in the abdomen, pelvis, or leg during a procedure where other arteries have already been accessed.
63 $91 $597
Vessel or growth occlusion with radiologist review
A procedure to block blood flow to growths or obstructed vessels, including review by a radiologist.
54 $6,734 $39,259
Nitroglycerin injection, 5 mg
An injection containing 5 mg of nitroglycerin.
54 $1 $5
New patient office visit, complex (60-74 min) 41 $160 $840
Complex radiation therapy planning 35 $130 $690
Calculation of radiation therapy dose 35 $51 $275
Radioelements for brachytherapy, any type, each 35 $13,677 $20,361
Special radiation treatment 34 $108 $544
Nuclear medicine liver study
A diagnostic imaging test that uses a small amount of radioactive material to evaluate liver function and structure.
31 $140 $800
Radioactive drug therapy via arterial tube
Administration of a radioactive therapeutic agent through a catheter inserted into an artery to target specific tissues.
30 $100 $471
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
28 $134 $708
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
28 $81 $256
Arterial tube insertion, first branch
A procedure to insert a tube into the first branch of an artery in the abdomen, pelvis, or leg.
27 $487 $5,443
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
26 $0 $2
Artery occlusion with radiologist review
A procedure to block an artery, accompanied by a radiologist's review of the results.
24 $5,620 $30,866
Technetium Tc-99m MAA diagnostic injection
A radioactive tracer injection used for diagnostic imaging studies. The dose administered is up to 10 millicuries.
23 $119 $730
Ultrasound of blood vessel, initial vessel
An ultrasound exam of a blood vessel that includes a radiologist's review of the initial vessel.
22 $750 $5,216
Nuclear medicine study, multiple areas
A diagnostic imaging test using radioactive substances to examine several body regions simultaneously. This procedure helps visualize internal organ function and structure across multiple areas.
22 $199 $1,200
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
15 $3 $13
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $136 $594
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
13 $5 $25
Fluoroscopic guidance for central vein access device
Use of live X-ray imaging to guide the placement or removal of a central vein access device.
12 $79 $371
Hydromorphone injection, up to 4 mg
An injection of hydromorphone, an opioid pain medication, with a dosage of up to 4 milligrams.
12 $3 $13
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $60 $357
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
92.4% medium
4.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$39,994
Total received (2018-2024)
Avg $5,713/year across 7 years
Top 3% in TX for radiation oncology
36
Companies
512
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,277 (50.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,088 (32.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,629 (16.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,496
2023
$4,349
2022
$7,525
2021
$1,559
2020
$6,911
2019
$8,927
2018
$8,227

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sirtex Medical Inc
$22,968
Boston Scientific Corporation
$5,572
BOSTON SCIENTIFIC CORPORATION
$1,857
Cook Medical LLC
$1,746
Embolx, Inc.
$1,600
Medtronic USA, Inc.
$832
Delcath Systems
$786
Cardiovascular Systems Inc.
$602
Merit Medical Systems Inc
$460
IsoRay, Inc
$400
Abbott Laboratories
$307
Medtronic, Inc.
$255
Bard Peripheral Vascular, Inc.
$204
Allergan Inc.
$183
Integra LifeSciences Corporation
$177
Cook Incorporated
$166
Agiliti Surgical, Inc.
$163
Wright Medical Technology, Inc.
$154
Janssen Pharmaceuticals, Inc
$146
Philips Electronics North America Corporation
$142
DAVOL INC.
$136
AngioDynamics, Inc.
$130
Ipsen Biopharmaceuticals, Inc
$124
Covidien LP
$116
Nevro Corp.
$103
W. L. Gore & Associates, Inc.
$101
ShockWave Medical, Inc
$93
Medtronic Vascular, Inc.
$86
Inari Medical, Inc.
$82
Stryker Corporation
$81
TriSalus Life Sciences, Inc.
$74
Terumo Medical Corporation
$52
Analogic Corporation
$38
Tactile Systems Technology Inc
$22
Adaptive Biotechnologies Corporation
$21
Surmodics, Inc.
$15
Top 3 companies account for 76.0% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ANGIO-SEAL · ANGIOJET · APDL · AURYON LASER SYSTEM 100-120 VAC · AZUR CX DETACHABLE · BEAD BLOCK · Brachytherapy Source · CLEARVUE · CODMAN CERTAS · CONTOUR · COOK MEDICAL ANGIOPLASTY · COOK MEDICAL CATHETERS · COOK MEDICAL FILTERS · COOK MEDICAL MICROPUNCTURE · COOK MEDICAL SELF-EXPANDING STENT · COOK MEDICAL STENTS · COOK MEDICAL ZILVER · COOK MEDICAL ZILVER PTX · COYOTE · Cook Medical Angioplasty · Cook Medical Catheters · Cook Medical Celect Platinum · Cook Medical Filters · Cook Medical GI Products · Cook Medical Micropuncture · Cook Medical Stents · Cook Medical Zilver · Cook Medical Zilver PTX · DIAMONDBACK PERIPHERAL · DIREXION · Diamondback Peripheral · ELUVIA · EMBOZENE · Emprint · FATHOM · FATHOM -16 · FLAIR · FLOWTRIEVER CATHETER · Flexitouch Plus · FlowTriever · GENERAL EMBOLICS · GENERAL THERAPIES · GENERAL THROMBECTOMY · GENERAL VASCULAR INTERVENTION · GENERAL - CRYOPLASTY · GENERAL - EMBOLICS · GENERAL - NON-VASCULAR INTERVENTION · GENERAL - ULTRASOUND · GENERAL ANGIOPLASTY · GENERAL EMBOLICS · GENERAL METALLIC STENTS · GENERAL NONVASCULAR INTERVENTION · GENERAL THROMBECTOMY · GENERAL VASCULAR INTERVENTION · GLIDEPATH · General - Atherectomy · General - Balloons · General - Embolics · General - IO Ablation · General - Therapies · General - Ultrasound · General - Vascular Intervention · HawkOne · Hepzato Kit · IGT Devices Und · IGT_D Peripheral · INNOVA · IVS - AUTOPLEX SYSTEM · JETSTREAM · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LUTONIX · Lunderquist · ONIVYDE · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · PHASIX · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Permcath · Prelude Ideal Hydrophilic Sheath Introducer · ROTALINK · RotaLink Burr · S · SALVATION · SIR-Spheres Microspheres · SPINEJACK · STRATTICE · SYNCHROMED · Senza · Sublime 014 Rx PTA Balloon Dilatation Catheter · Supera peripheral stent system · THERASPHERE · TIGRIS Stent · TRINAV INFUSION SYSTEM · TheraSphere Y90 Glass Microspheres 10 GBq · Trek · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with Heparin Bioactive Surface · Vascular Lithotripsy · XARELTO · ZILVER VENA · Zilver 635 · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in radiation oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for radiation oncology in TX.

Equivalent to $220 per 100 Medicare services performed
Looking for a radiation oncology specialist in Dallas?
Compare radiation oncologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
611
Per 100K population
23.5
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Van Meter is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Van Meter experienced with injection, propofol, 10 mg?
Based on Medicare claims data, Dr. Van Meter performed 7,425 injection, propofol, 10 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Van Meter receive payments from pharmaceutical companies?
Yes. Dr. Van Meter received a total of $39,994 from 36 companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Van Meter's costs compare to other radiation oncologists in Dallas?
Dr. Van Meter's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Van Meter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →